Myriad Genetics Inc
(MYGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MYGN | AZN | AMGN | GILD | VRTX |
| Company | Myriad Genetics Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 5.73 | 93.37 | 341.66 | 139.75 | 479.03 |
| High | 5.75 | 93.53 | 347.27 | 140.51 | 484.35 |
| Low | 5.53 | 92.57 | 338.75 | 138.23 | 473.86 |
| Latest | 5.54 | 92.59 | 342.94 | 139.55 | 475.68 |
| Change | -0.18 | -0.63 | +0.72 | -0.17 | -2.23 |
| % Change | -3.15% | -0.68% | +0.21% | -0.12% | -0.47% |
| Volume | 668,071 | 6,467,376 | 3,144,117 | 7,147,608 | 1,497,883 |
| 20-Day Average Volume | 907,534 | 9,274,299 | 2,692,801 | 7,436,355 | 1,508,734 |
| Previous Close | 5.72 | 93.22 | 342.22 | 139.72 | 477.91 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 6.10 | 93.36 | 334.78 | 127.15 | 461.45 |
| 20-Day Raw Stochastic | 4.45% | 47.52% | 70.58% | 91.30% | 79.77% |
| 20-Day Relative Strength | 35.98 | 51.32 | 56.96 | 67.44 | 59.21 |
| Weighted Alpha | -43.83 | +33.76 | +23.68 | +46.75 | +8.51 |
| Today's Opinion | 56% Sell | 88% Buy | 100% Buy | 100% Buy | 88% Buy |
| Previous Opinion | 56% Sell | 88% Buy | 100% Buy | 100% Buy | 88% Buy |
| Last Month's Opinion | 24% Sell | 100% Buy | 96% Buy | 80% Buy | 72% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -8.58% since 01/22/26 | +0.98% since 01/22/26 | -1.19% since 01/22/26 | +6.41% since 01/22/26 | +1.78% since 01/22/26 |
| Low | 5.53 on 01/29/26 | 91.44 on 01/23/26 | 338.75 on 01/29/26 | 131.00 on 01/23/26 | 462.73 on 01/23/26 |
| High | 6.02 on 01/23/26 | 96.18 on 01/27/26 | 353.25 on 01/27/26 | 141.71 on 01/27/26 | 485.00 on 01/27/26 |
| 1-Month | |||||
| %Chg | -12.20% since 12/29/25 | +0.08% since 12/29/25 | +4.04% since 12/29/25 | +11.72% since 12/29/25 | +3.46% since 12/29/25 |
| Low | 5.47 on 01/20/26 | 89.04 on 01/21/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 429.00 on 01/20/26 |
| High | 7.15 on 01/12/26 | 96.51 on 01/07/26 | 353.25 on 01/27/26 | 141.71 on 01/27/26 | 487.52 on 01/07/26 |
| 3-Month | |||||
| %Chg | -29.96% since 10/29/25 | +12.60% since 10/29/25 | +17.54% since 10/29/25 | +17.76% since 10/29/25 | +14.01% since 10/29/25 |
| Low | 5.47 on 01/20/26 | 80.48 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 403.16 on 11/04/25 |
| High | 8.38 on 11/03/25 | 96.51 on 01/07/26 | 353.25 on 01/27/26 | 141.71 on 01/27/26 | 487.52 on 01/07/26 |
| 6-Month | |||||
| %Chg | +35.12% since 07/29/25 | +25.16% since 07/29/25 | +12.97% since 07/29/25 | +22.17% since 07/29/25 | +1.55% since 07/29/25 |
| Low | 3.76 on 08/01/25 | 72.89 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 362.50 on 08/11/25 |
| High | 8.59 on 10/16/25 | 96.51 on 01/07/26 | 353.25 on 01/27/26 | 141.71 on 01/27/26 | 487.52 on 01/07/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 533,184 | 289,151,296 | 184,278,976 | 173,347,824 | 121,254,848 |
| Shares Outstanding, K | 93,214 | 3,101,816 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 837,600,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -127,300,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 205,700,000 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | -27,400,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | 1.81 | 0.34 | 0.45 | 0.33 | 0.31 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.00 on 11/03/25 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 02/23/26 | 02/10/26 | 02/03/26 | 02/10/26 | 02/12/26 |
| Most Recent Dividend | 1.750 on 06/15/09 | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.92 | 16.06 | 17.21 | 30.97 |